Hi Joseph
Don't forget to include heterophilic antibody interference which will lead on to unnecessary follow up and anxiety of some patients undergoing a tumour marker screen.
cheers
Trevor
I am preparing a talk entitled "benefits and risks of tumour markers measurements" and I would like to use as an example of request where the balance between benefits and harms is likely to bend towards harms the example of "tumour marker screen" where several markers are requested for patients with rather non-specific symptoms
does anyone know of published guidelines where experts recommended against such "tumour marker screens"?
many thanks in advance,Dr Joseph Watine, PH, AIHP, PharmD, AAHU, EurClinChem
Laboratoire de Biologie Polyvalente
Centre Hospitalier Général
12027 Rodez Cedex 9
France
Faites une bonne action avec Bing Solidaire !
C'est ici ! ------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/